5-hydroxy-1-methyl-2-(di-n-propylamino)tetralin has been researched along with 8-hydroxy-2-(di-n-propylamino)tetralin in 4 studies
Studies (5-hydroxy-1-methyl-2-(di-n-propylamino)tetralin) | Trials (5-hydroxy-1-methyl-2-(di-n-propylamino)tetralin) | Recent Studies (post-2010) (5-hydroxy-1-methyl-2-(di-n-propylamino)tetralin) | Studies (8-hydroxy-2-(di-n-propylamino)tetralin) | Trials (8-hydroxy-2-(di-n-propylamino)tetralin) | Recent Studies (post-2010) (8-hydroxy-2-(di-n-propylamino)tetralin) |
---|---|---|---|---|---|
5 | 0 | 0 | 3,530 | 7 | 389 |
Protein | Taxonomy | 5-hydroxy-1-methyl-2-(di-n-propylamino)tetralin (IC50) | 8-hydroxy-2-(di-n-propylamino)tetralin (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.0012 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0032 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.81 | |
D(2) dopamine receptor | Bos taurus (cattle) | 0.8 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.81 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.81 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 2.8959 | |
Lysosomal alpha-glucosidase | Bos taurus (cattle) | 0.0021 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersson, B; Arvidsson, LE; Carlsson, A; Clark, D; Hacksell, U; Hjorth, S; Johansson, AM; Sanchez, D; Svensson, K; Wikström, H | 1 |
Baldessarini, RJ; Campbell, A; Froimowitz, M; Gao, YG; Neumeyer, JL | 1 |
Baldessarini, RJ; Froimowitz, M; Neumeyer, JL | 1 |
Andersson, B; Arvidsson, LE; Carlsson, A; Clark, D; Hacksell, U; Hjorth, S; Johansson, AM; Nilsson, JL; Sanchez, D; Svensson, K | 1 |
4 other study(ies) available for 5-hydroxy-1-methyl-2-(di-n-propylamino)tetralin and 8-hydroxy-2-(di-n-propylamino)tetralin
Article | Year |
---|---|
(+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors.
Topics: 4-Butyrolactone; 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Apomorphine; Behavior, Animal; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Male; Motor Activity; Naphthalenes; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Serotonin; Stereoisomerism; Tetrahydronaphthalenes | 1986 |
Neuropharmacology and stereochemistry of dopamine receptor agonist and antagonist enantiomeric pairs.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aporphines; Dopamine; Molecular Conformation; Naphthalenes; Piperidines; Receptors, Dopamine; Stereoisomerism; Structure-Activity Relationship; Tetrahydronaphthalenes | 1988 |
A stereochemical explanation of the dopamine agonist and antagonist activity of stereoisomeric pairs.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Apomorphine; Chemical Phenomena; Chemistry; Dopamine; Dopamine Antagonists; Molecular Conformation; Naphthalenes; Piperidines; Receptors, Dopamine; Stereoisomerism; Structure-Activity Relationship; Tetrahydronaphthalenes; Thermodynamics | 1986 |
Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Brain; Dihydroxyphenylalanine; Male; Motor Activity; Naphthalenes; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereoisomerism; Tetrahydronaphthalenes | 1985 |